Normal view MARC view ISBD view

Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. [electronic resource]

By:

McShea, A

Contributor(s):

Producer: 19970703Description: 1933-9 p. digitalISSN:

0002-9440

Subject(s):

In: The American journal of pathology vol. 150

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

1 Pharmacogenetics.
by David, Sean P
2 Should we offer routine breast cancer screening with mammography?
by David, Sean P
3 Should we prescribe antibiotics for acute conjunctivitis?
by David, Sean P
4 Novel Methodologies and the Need for Big Data in Nicotine and Tobacco Genetics Research.
by David, Sean P
5 Should we use multiple risk factor interventions for the primary prevention of coronary heart disease?
by David, Sean P
6 Commentary on Chen et al. (2014): another step on the road to clinical utility of pharmacogenetics for smoking cessation?
by David, Sean P
7 Clinical and Personal Utility of Genetic Risk Testing.
by David, Sean P
8 Are family physicians willing to use pharmacogenetics for smoking cessation therapy?
by Stamp, Michael J
9 Comment on "The public health implications of smoking-induced decreased serum and red blood cell folate levels".
by David, Sean P
10 Smoking cessation in primary care.
by David, Sean P
11 Gene by Environment Interaction Linking the Chromosome 15q25 Locus with Cigarette Consumption and Lung Cancer Susceptibility--Are African American Affected Differently?--Authors' Reply.
by David, Sean P
12 Genetic variation in the dopamine pathway and smoking cessation.
by David, Sean P
13 Fellowship training in family medicine at Brown: adding depth to breadth.
by Long, Rick
14 Smoking cessation.
by Koplan, Kate E
15 Successful Latino community partnership program for smoking cessation.
by David, Sean P
16 A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation.
by Welton, Nicky J
17 Tobacco Genomics: Complexity and Translational Challenges.
by Bergen, Andrew W
18 Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data.
by Munafò, Marcus R
19 Opioid antagonists for smoking cessation.
by David, Sean P
20 Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention.
by Ioannidis, John P A